BridgeMD
Compares treatment options for Stroke
Official title Endarterectomy Versus Stenting in Patients With Symptomatic Severe Carotid Stenosis - 2
ClinicalTrials.gov ID: NCT07054060
What this study is testing
- What it's testing
- Carotid stenosis caused by atherosclerosis is a significant risk factor for ischemic stroke, accounting for up to 15% of all strokes and transient ischemic attacks. Randomized clinical trials (RCTs) have demonstrated the benefits of carotid endarterectomy (CEA) in reducing stroke risk in patients with severe symptomatic carotid stenosis.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient age 18 years or over
- Hemispheric or retinal transient ischemic attack or a non-disabling stroke (or retinal infarct) within 15 days before enrolment
- Stenosis of 50% to 99% in the symptomatic carotid artery (NASCET method) for whom revascularisation is decided according to guidelines
You likely can't join if
- Patients unwilling or unable to participate in follow-up for whatever reason
- Preexisting disability (Modified Rankin Score ≥ 3)
- Nonatherosclerotic carotid disease
- Severe tandem lesions
- Previous revascularization of the symptomatic carotid stenosis
- History of bleeding disorder
See the full eligibility criteria
- Patient age 18 years or over
- Hemispheric or retinal transient ischemic attack or a non-disabling stroke (or retinal infarct) within 15 days before enrolment
- Stenosis of 50% to 99% in the symptomatic carotid artery (NASCET method) for whom revascularisation is decided according to guidelines
- Patients unwilling or unable to participate in follow-up for whatever reason
- Preexisting disability (Modified Rankin Score ≥ 3)
- Nonatherosclerotic carotid disease
- Severe tandem lesions
- Previous revascularization of the symptomatic carotid stenosis
- History of bleeding disorder
- Unstable angina
- Contraindication to dual antiplatelet therapy
- Contraindication to MRI
- Life expectancy of less than 2 years
- Percutaneaous or surgical intervention within 30 days before or after the study procedure
- Stenotic lesion on arterial workup appeared as not a factor in the selection
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.